Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograft.

After therapeutic hormone deprivation, most prostate cancer (PrCa) cells develop androgen-independent (AI) growth. PrCa is highly heterogeneous and multifocal, suggesting that several molecular processes or pathways may be contributing to AI. The human LuCaP 23.